Q2 2019

Filed Aug 7, 2019 · 10-Q · 38 days after period end · 0001564590-19-030067

Q2 2019 · 10-Q

Revenue

$379.00K

±0.0% vs Q2 2018

Net Income

-$14.92M

N/M vs Q2 2018

EPS Diluted

-$0.47

N/M vs Q2 2018

Operating Income-$15,374,000N/M

Operating Cash Flow

Same quarter

Metric	Q2 2019	Q2 2018	Q2 2017	Q2 2016
Revenue	$379.00K	$379.00K	$305.00K	$305.00K
Net Income	-$14.92M	-$18.39M	-$13.64M	-$8.36M
EPS Diluted	-$0.47	$0.74	-$0.47	-$0.47

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Syndax Pharmaceuticals Inc · CIK 1395937 · Engraved from SEC EDGAR